Concomitant T790M mutation and small‐cell lung cancer transformation after acquired resistance to epidermal growth factor receptor‐tyrosine kinase inhibitor

Lignende værker

• Should Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Be Continued beyond Progressive Disease?
  af: Kim, Young Hak, et al.
  Udgivet: (2011)
• Predictors of Acquired T790M Mutation in Patients Failing First- or Second-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors
  af: Chai CS, et al.
  Udgivet: (2020-07-01)
• Predictors of Acquired T790M Mutation in Patients Failing First- or Second-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors
  af: Chai, Chee-Shee, et al.
  Udgivet: (2020)
• Resistance to epidermal growth factor receptor tyrosine kinase inhibitors, T790M, and clinical trials
  af: O’Kane, G.M., et al.
  Udgivet: (2018)
• A case of resistance to tyrosine kinase inhibitor therapy: small cell carcinoma transformation concomitant with plasma-genotyped T790M positivity
  af: Xu, Yanjun, et al.
  Udgivet: (2017)